Presidio Medical has received an IDE approval from the FDA, enabling a pivotal study of its neuromodulation platform.

Epiminder has reported the outcomes from the landmark UMPIRE (sUb-scalp Monitoring ePileptic selzuREs) trial evaluating ...

Spanish company Aortyx has secured €13.8m ($15.8m) in a Series A financing round to further develop its bioresorbable patch, ...

The health secretary addressed NHS employees a day after the £29bn NHS funding was announced. A £29bn investment into the ...

GE HealthCare has released software combining its own imaging functionalities with tools enabled by a platform developed by ...

Cognito has reported outcomes from a post hoc analysis of its OVERTURE trial, indicating that the Spectris AD can slow the ...

Amid ongoing trade policy debates, leaders from the medtech industry convened on Capitol Hill alongside the Advanced Medical ...

Wandercraft has raised $75m in a Series D funding round to introduce the self-balancing personal exoskeleton, Eve, to market ...

Sofinnova Partners has partnered with NVIDIA in a move intended to equip its life sciences portfolio companies with faster ...

The US FDA has granted 510(k) clearance to Neurent Medical's NEUROMARK System for the treatment of individuals with chronic ...

The UK’s National Health Service (NHS) is receiving a £29bn ($39.1bn) funding boost, reflecting a 3% annual rise on current levels over the next three years to reach £226bn ($305.7bn) by 2029.

Somnee announced that it has secured $10m in a seed extension round to advance its AI-powered neurotech sleep wearables.